These suggest that, despite HDAC7-high expressing tumors are heavily infiltrated with immune cells that could kill cancer cells, the effectiveness of immune responses might be significantly abrogated at the level of immune checkpoint signaling. This evidence concerns the gene HDAC7 and cancer.